image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Polypipe

October 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PLP
  • Price:
  • 373p
Polypipe, the manufacturer of plastic piping and ventilation systems, produced resilient interim results for the six months to June. The company had to bear delays to new orders caused by bad weather and other project delays in road and commercial projects but still achieved consensus forecasts with pretax profit falling 4.6% to £32.9m on sales of £210m (H1 2017: £210m). Strong cash flow reduced borrowings with net debt/ EBITDA just 1.7x versus 2x in 2017.The resilient performance came thanks to its UK residential systems side, which grew sales 5.9% to £119m driven by new housebuilding growth (helped by Government schemes like ‘Help to Buy’). However, the RMI (repairs, maintenance) sector continu ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X